Exhibit 99.1 SETTLEMENT AGREEMENT, INDEMNIFICATION AND MUTUAL RELEASE This Settlement Agreement, Indemnification and Mutual Release ("Agreement"), effective April 24, 2009, is by and among Malcolm Skolnick, an individual residing at 8993 Briar Forest...Settlement Agreement • May 7th, 2009 • Cytogenix Inc • Services-medical laboratories • Texas
CYTOGENIX, INC.Warrant Agreement • September 25th, 2001 • Cytogenix Inc • Services-medical laboratories • Texas
EXHIBIT 10.3 LICENSE AGREEMENT This License Agreement ("Agreement"), dated February 3, 2000, and effective as of the EFFECTIVE DATE (defined below), is entered into at Houston, Texas by and between CytoGenix, Inc. a Nevada corporation having an office...License Agreement • July 19th, 2000 • Cytogenix Inc • Services-medical laboratories • Texas
RECITALSEmployment Agreement • November 28th, 2000 • Cytogenix Inc • Services-medical laboratories • Texas
Exhibit 99.2 CONSULTING AGREEMENT This Consulting Agreement (AGREEMENT) is made effective March 20, 2009 (EFFECTIVE DATE) and is entered into by CytoGenix, Inc. with its principal place of business at 3100 Wilcrest Drive, Houston, TX 77042 (COMPANY),...Consulting Agreement • April 3rd, 2009 • Cytogenix Inc • Services-medical laboratories
EXHIBIT 10.7 SPONSORED RESEARCH AGREEMENT THIS AGREEMENT is made by and between CytoGenix, Inc. whose address is 9881 South Wilcrest, Houston, Texas 77099 (hereinafter "SPONSOR") and Baylor College of Medicine, whose address is One Baylor Plaza,...Sponsored Research Agreement • November 28th, 2000 • Cytogenix Inc • Services-medical laboratories
EXHIBIT 10.9 STOCK RIGHTS AGREEMENT This Stock Rights Agreement ("Agreement"), will be effective as of March 10, 2000 (the "Effective Date") is between CytoGenix, Inc., a Nevada corporation ("CytoGenix") and Argyll Scientific, L.L.C., a Texas limited...Stock Rights Agreement • September 25th, 2001 • Cytogenix Inc • Services-medical laboratories • Texas
RECITALSCommercialization Agreement • July 19th, 2000 • Cytogenix Inc • Services-medical laboratories • Nevada
EXHIBIT 10.8 RESEARCH AND DEVELOPMENT AGREEMENT This Research and Development Agreement ("Agreement"), effective as of March 10, 2000 ("Effective Date"), is between CytoGenix, Inc., a Nevada corporation ("CytoGenix"), and Argyll Scientific, L.L.C., a...Research and Development Agreement • September 25th, 2001 • Cytogenix Inc • Services-medical laboratories • Texas
EXHIBIT 10.4 TECHNOLOGY TRANSFER AGREEMENT THIS AGREEMENT is made by and between InGene,lnc. (INGENE), a Kansas corporation having an address at 8496 West 116th Street, Overland Park, Kansas 66210 and Cryogenic Solutions, Inc. (CYGS), a Nevada...Technology Transfer Agreement • July 19th, 2000 • Cytogenix Inc • Services-medical laboratories • Texas
CONSULTING AGREEMENTConsulting Agreement • September 10th, 2007 • Cytogenix Inc • Services-medical laboratories • Texas
This Consulting Agreement ("Agreement") is entered into this 4th day of September, 2007 between CHASSEUR Corporation, located at 3020 Bellaire Ranch Drive, #1517, Fort Worth, TX 76109 ("Consultant"), a business engaged in providing consulting services, through its partners, subsidiaries or affiliates and CYTOGENIX, INC., located at 3100 Wilcrest Drive, Houston, TX 77042, a Nevada corporation located in Houston, Texas (“Client” or the “Company”), in connection with the rendering by Consultant to Client of consulting services, as described herein below, for and in consideration of the compensation described.
AGREEMENTLoan Agreement • April 15th, 2002 • Cytogenix Inc • Services-medical laboratories
This agreement is made as of the 6th day of April, 2001, between CytoGenix, Inc., 9881 South Wilcrest, Houston, TX 77099 (“CytoGenix”) and HEMCO Onshore, L.L.C., 1601 Elm Street, Suite 1500, Dallas, Texas 75201 and concerns the terms and conditions of a secured loan to be made by Hemco to CytoGenix in the amount of Two Hundred Fifty Thousand Dollars ($250,000.00) without interest (“the Loan”), such Loan to be made in order to pay vendors of CytoGenix. All of the representations made herein by CytoGenix to Hemco are material to the agreement of Hemco to make the Loan. For and in consideration of the Loan and other good and valuable consideration, CytoGenix and Hemco contract, as follows:
SETTLEMENT AGREEMENT AND MUTUAL RELEASESettlement Agreement • July 7th, 2008 • Cytogenix Inc • Services-medical laboratories • Texas
This Settlement Agreement and Mutual Release ("Agreement"), effective June 30, 2008, is by and among Frank Vazquez (“Vazquez”) and Lawrence Wunderlich (“Wunderlich”) (collectively, “Claimants”), and CytoGenix, Inc. (“CytoGenix”).
RECITALSEmployment Agreement • July 19th, 2000 • Cytogenix Inc • Services-medical laboratories • Texas
EARNEST MONEY CONTRACT FOR DESIGN/BUILD PROJECTEarnest Money Contract • November 3rd, 2006 • Cytogenix Inc • Services-medical laboratories • Texas
This Earnest Money Contract for Design/Build Project (“Contract”) is entered into as of the Effective Date, as herein defined, between GSL CONSTRUCTORS, LTD., as Seller (“Seller”), and CYTOGENIX, INC., a Nevada corporation (Employer ID: 76-0484097), as Buyer (“Buyer”), and is on the following terms and conditions of agreement between Seller and Buyer:
SUPPLY AGREEMENTSupply Agreement • March 28th, 2006 • Cytogenix Inc • Services-medical laboratories • Delaware
THIS SUPPLY AGREEMENT (this “Agreement”) by and between GE Healthcare Bio-Sciences Corp., a Delaware corporation, located at 800 Centennial Avenue, Piscataway, New Jersey 08855 USA (“GEHC”), and Cytogenix Inc., a Nevada corporation, located at 3100 Wilcrest Drive, Suite 140, Houston, TX 77042 (“Buyer”), is effective as of the date of the last signature hereto.
EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 2008 • Cytogenix Inc • Services-medical laboratories • Texas
This Employment Agreement (“Agreement”) is dated this 17th day of April, 2008 to be effective as of September 1, 2007 (the “Effective Date”) by and between GREG S. TAYLOR (the “Employee”) and CYTOGENIX, INC., a Nevada corporation (the “Company”).
CONSULTING AGREEMENTConsulting Agreement • April 15th, 2002 • Cytogenix Inc • Services-medical laboratories • Texas
This Consulting Agreement (“Agreement”) is entered into this 19th day of March, 2002 between Eurotrade Financial, Inc., a Texas corporation engaged in providing consulting services and finder services, through its partners, subsidiaries or affiliates located at 6371 Richmond Ave., Suite 200, Houston, Texas 77057 (“Eurotrade” or “Consultant”), and CytoGenix, Inc., a Nevada corporation located at 9881 S. Wilcrest, Houston, Texas 77099 (“CYGX,” “Client” or the “Company”), in connection with the rendering by Eurotrade to CYGX of consulting services and finder services, as described herein below, for and in consideration of the compensation described.
CONSULTING AGREEMENTConsulting Agreement • April 15th, 2002 • Cytogenix Inc • Services-medical laboratories • Texas
THIS CONSULTING AGREEMENT (hereinafter “AGREEMENT”) is made this 15th day of February, 2001 (EFFECTIVE DATE) and is entered into by CytoGenix, Inc. with its principal place of business at 9881 South Wilcrest, Houston, Texas, 77099 (hereinafter “CYGX”), and Michael D. Skillern whose address is 5868 A-1 Westheimer No. 466, Houston, Texas 77057 (hereinafter “CONSULTANT”).
CONSULTING AGREEMENT BETWEEN ORIGENESIS, LLC & FARM TEAM MENTORS, LLC (“CONSULTANTS”) AND CYTOGENIX, INC.Consulting Agreement • April 15th, 2002 • Cytogenix Inc • Services-medical laboratories • Texas
This Agreement, made in Houston, Harris County, Texas, and entered into this 18th day of October 2001, by and between Farm Team Mentors, LLC (hereinafter “FTM”), a Texas limited liability company, and Origenesis, LLC (“hereinafter “ORIGENESIS”), a Texas limited liability company, jointly “CONSULTANTS”, and Cytogenix, Inc. (hereinafter “CYGX”), a Texas publicly-traded corporation, collectively the “Parties” or individually “Party”, is made for the purposes of providing consultation services to CYGX in the additional capitalization of CYGX’S business.
SUPPLY AGREEMENT AMENDMENT NO. 1Supply Agreement • June 13th, 2007 • Cytogenix Inc • Services-medical laboratories • Delaware
THIS AMENDMENT NO. 1 (“Amendment No. 1”), effective as of the 24th day of March, 2007 (“Effective Date”), to the Supply Agreement dated March 24, 2006 by and between GE Healthcare Bio-Sciences Corp., a Delaware corporation, located at 800 Centennial Avenue, Piscataway, New Jersey 08855 USA (“GEHC”), and Cytogenix Inc., a Nevada corporation, located at 3100 Wilcrest Drive, Suite 140, Houston, TX 77042 (“Buyer”) (the “Supply Agreement”).
